Suppr超能文献

患者和公众参与(PPI)在乳腺癌和肾病试验中的结局选择。

Patient and Public Involvement (PPI) in outcome selection in breast cancer and nephrology trials.

机构信息

Trials Research and Methodologies Unit, HRB Clinical Research Facility, University College Cork, Cork, Ireland.

School of Public Health, University College Cork, Cork, Ireland.

出版信息

Trials. 2023 Feb 7;24(1):93. doi: 10.1186/s13063-022-06980-9.

Abstract

We recently reported that according to patients and healthcare professionals in breast cancer and nephrology trials, teams conducting the trials got their choice of primary outcome wrong (72% of the time) more often than they got it right (28% of the time). A Patient and Public Involvement (PPI) representative, co-author of this letter, asked (on Twitter) whether PPI contributors had been involved in the design of the original trials and by extension the outcome selection. The purpose of this study was to answer this question.

摘要

我们最近报道称,根据乳腺癌和肾病学试验中的患者和医疗保健专业人员的反馈,进行试验的团队在选择主要结果时出错的频率(72%)高于他们选对的频率(28%)。一位患者和公众参与(PPI)代表、这封信的共同作者在 Twitter 上询问,PPI 参与者是否参与了原始试验的设计,以及试验结果的选择。本研究旨在回答这个问题。

相似文献

本文引用的文献

9
Patient involvement in clinical research: why, when, and how.患者参与临床研究:为何、何时以及如何参与。
Patient Prefer Adherence. 2016 Apr 27;10:631-40. doi: 10.2147/PPA.S104259. eCollection 2016.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验